Kintor Pharmaceutical was founded in China. Kintor's pyrilutamide AR antagonist will treat hair loss (androgenic alopecia). Phase 3 trials begin in early 2022.
www.hairlosscure2020.com
Update: August 11, 2022 — Great news per a Chinese contact. It looks like Kintor
may finally present the results of its Phase 2 Chinese trials of Pyrilutamide (KX-826) for hair loss on September 3 at 8:20 pm . The presenter will be Dr. Zhou Cheng from Peking University People’s Hospital (where Kintor’s Phase 3 trials are also being conducted right now).